Christopher G. King

发表

Modeling microbial diversity with metabolic trade-offs

Bo Liu, Zhiyuan Li, Ned S. Wingreen, 2019 .

IL-17 contributes to CD4-mediated graft-versus-host disease.

Christopher G. King, M. V. D. van den Brink, Y. Iwakura, 2009, Blood.

Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease.

Christopher G. King, M. V. D. van den Brink, Z. Fuks, 2009, Blood.

Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors

Michel Sadelain, Isabelle Riviere, Glenn Heller, 2008, Nature Biotechnology.

Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation.

Christopher G. King, M. V. D. van den Brink, Sydney X. Lu, 2008, Blood.

Organ-derived dendritic cells have differential effects on alloreactive T cells.

Christopher G. King, M. V. D. van den Brink, G. Heller, 2008, Blood.

DiseaseAmeliorates Experimental Graft-versus-Host Allogeneic Bone Marrow Transplantation Absence of P-Selectin in Recipients of

Christopher G. King, R. Jenq, A. M. Holland, 2010 .

Absence of P-Selectin in Recipients of Allogeneic Bone Marrow Transplantation Ameliorates Experimental Graft-versus-Host Disease

Christopher G. King, R. Jenq, M. V. D. van den Brink, 2010, The Journal of Immunology.

Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation

Christopher G. King, R. Jenq, M. V. D. van den Brink, 2011, PloS one.

Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity.

Christopher G. King, M. V. D. van den Brink, A. Chow, 2007, Blood.

Rapidly proliferating CD44 hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation

Christopher G. King, Sydney X Lu, V. Hubbard, 2008 .

The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Christopher G. King, R. Jenq, M. V. D. van den Brink, 2010, The Journal of clinical investigation.

Luteinizing Hormone-Releasing Hormone Enhances T Cell Recovery following Allogeneic Bone Marrow Transplantation1

Christopher G. King, S. Chen‐Kiang, M. V. D. van den Brink, 2009, The Journal of Immunology.

Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.

Christopher G. King, J. Wolchok, M. Perales, 2009, Blood.

Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.

Christopher G. King, D. Scheinberg, R. Jenq, 2010, Journal of the National Cancer Institute.

Allogeneic Bone Marrow Transplantation Enhances T Cell Recovery following Luteinizing Hormone-Releasing Hormone

Christopher G. King, S. Chen‐Kiang, M. Samstein, 2013 .

Allogeneic Bone Marrow Transplantation Enhances T Cell Recovery following Luteinizing Hormone-Releasing Hormone den Brink

Christopher G. King, S. Chen‐Kiang, R. Samstein, 2009 .

STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease.

Christopher G. King, R. Balderas, G. Altan-Bonnet, 2008, Blood.

The T Cell Cytolytic Molecules Fas Ligand and TRAIL, the Trafficking Molecules CCR9, β7 Integrin and PSGL-1, and the Immune Modulating Molecules OX40, CEACAM1, and CTLA4 Are Required for Thymic Graft-Versus-Host Disease

Christopher G. King, R. Jenq, A. Houghton, 2008 .

Off‐the‐shelf tumor immunotherapy with genetically enhanced allogeneic T cell precursors

Christopher G. King, R. Jenq, J. Zakrzewski, 2008 .

Discovery and Validation of STAT-3 and ERK1/2 Phosphorylation as Critical for the Function of Alloactivated T Cells in Acute Graft-Versus-Host-Disease Via a Novel Technique for Drug Discovery.

Christopher G. King, R. Campos, A. Chow, 2007 .